Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment
Open Access
- 26 November 2024
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 46 (1) , 71-76
Abstract
Objective: Multiplex polymerase chain reaction (PCR) panels for stool testing may be used to diagnose Clostridioides difficile, which can circumvent more appropriate targeted C. difficile testing, resulting in treatment of incidentally detected colonization. We sought to reduce C. difficile diagnosis via a gastrointestinal pathogen panel (GIPP).Design: Quasi-experimental, pre/post, retrospective cohort study from January 1, 2022, to January 31, 2024.Setting: Mayo Clinic Arizona—a single academic medical center and associated clinics.Patients: Adult patients receiving C. difficile testing and/or treatment.Methods: Preferred C. difficile testing consisted of glutamate dehydrogenase and toxin antigen immunoassay, followed by toxin gene testing for discrepant results. The GIPP contained 22 targets during the baseline period with C. difficile removed during the postintervention period. Surveys were provided to provider and nursing groups, separately, to identify C. difficile ordering practices and knowledge gaps.Results: At baseline, from January 1, 2022, to January 31, 2023, 2,772 GIPPs were completed for 2,307 unique patients (∼7 per day), primarily for outpatients (1,805 of 2,772, 65%). The most common positive target was C. difficile (517 of 1,018, 51%), which resulted in treatment for C. difficile infection in 94.9% (337 of 355) of cases. Following GIPP C. difficile target removal, GIPP orders decreased from 3.23 to 2.7 per 1,000 patient visits (P < .001). Prescribing of C. difficile treatments decreased in the postintervention period in inpatient and outpatient settings. There were no cases of delayed C. difficile diagnosis during the postintervention period.Conclusions: Removing C. difficile from the GIPP resulted in effective diagnostic and antimicrobial stewardship without resulting in delayed diagnoses.Keywords
This publication has 21 references indexed in Scilit:
- Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategiesGut Microbes, 2023
- Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trialThe Lancet Infectious Diseases, 2023
- Diagnostic Stewardship to Prevent Diagnostic ErrorJAMA, 2023
- Principles of diagnostic stewardship: A practical guide from the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task ForceInfection Control & Hospital Epidemiology, 2023
- The effect of gastrointestinal pathogen panel (GIP) on antibiotic managementAntimicrobial Stewardship & Healthcare Epidemiology, 2021
- Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitalsDiagnostic Microbiology and Infectious Disease, 2021
- Clostridium difficile: Diagnosis and the Consequence of Over DiagnosisInfectious Diseases and Therapy, 2021
- Laboratory Tests for the Diagnosis of Clostridium difficileClinics in Colon and Rectal Surgery, 2020
- Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimensDiagnostic Microbiology and Infectious Disease, 2018
- Colonization Versus Carriage of Clostridium difficileInfectious Disease Clinics of North America, 2015